nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—Carboplatin—testicular cancer	0.426	0.539	CbGbCtD
Propylthiouracil—MPO—Cisplatin—testicular cancer	0.364	0.461	CbGbCtD
Propylthiouracil—Drug fever—Chlorambucil—testicular cancer	0.00871	0.0413	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Chlorambucil—testicular cancer	0.00601	0.0285	CcSEcCtD
Propylthiouracil—Lung infiltration—Bleomycin—testicular cancer	0.0048	0.0228	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Etoposide—testicular cancer	0.00455	0.0216	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Chlorambucil—testicular cancer	0.00411	0.0195	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Ifosfamide—testicular cancer	0.00398	0.0189	CcSEcCtD
Propylthiouracil—Neuritis—Chlorambucil—testicular cancer	0.00389	0.0185	CcSEcCtD
Propylthiouracil—Neuritis—Vinblastine—testicular cancer	0.00357	0.0169	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Bleomycin—testicular cancer	0.00318	0.0151	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Etoposide—testicular cancer	0.00314	0.0149	CcSEcCtD
Propylthiouracil—Allergic cutaneous angiitis—Methotrexate—testicular cancer	0.00286	0.0136	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Ifosfamide—testicular cancer	0.00272	0.0129	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Epirubicin—testicular cancer	0.00255	0.0121	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Chlorambucil—testicular cancer	0.00247	0.0117	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Doxorubicin—testicular cancer	0.00236	0.0112	CcSEcCtD
Propylthiouracil—Renal failure acute—Chlorambucil—testicular cancer	0.00229	0.0108	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Etoposide—testicular cancer	0.00215	0.0102	CcSEcCtD
Propylthiouracil—Ageusia—Cisplatin—testicular cancer	0.00205	0.00971	CcSEcCtD
Propylthiouracil—Vasculitis—Ifosfamide—testicular cancer	0.00197	0.00935	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Dactinomycin—testicular cancer	0.00197	0.00935	CcSEcCtD
Propylthiouracil—Liver injury—Cisplatin—testicular cancer	0.00197	0.00935	CcSEcCtD
Propylthiouracil—Erythema nodosum—Epirubicin—testicular cancer	0.00197	0.00934	CcSEcCtD
Propylthiouracil—Lung infiltration—Methotrexate—testicular cancer	0.00194	0.00921	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Methotrexate—testicular cancer	0.00188	0.00893	CcSEcCtD
Propylthiouracil—Leukocytoclastic vasculitis—Methotrexate—testicular cancer	0.00185	0.0088	CcSEcCtD
Propylthiouracil—Erythema nodosum—Doxorubicin—testicular cancer	0.00182	0.00864	CcSEcCtD
Propylthiouracil—Hepatic failure—Dactinomycin—testicular cancer	0.00169	0.00804	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00159	0.00756	CcSEcCtD
Propylthiouracil—Body temperature increased—Carboplatin—testicular cancer	0.00159	0.00756	CcSEcCtD
Propylthiouracil—Jaundice—Chlorambucil—testicular cancer	0.00158	0.00752	CcSEcCtD
Propylthiouracil—Hepatic failure—Ifosfamide—testicular cancer	0.00155	0.00737	CcSEcCtD
Propylthiouracil—Renal failure acute—Ifosfamide—testicular cancer	0.00151	0.00717	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Vinblastine—testicular cancer	0.00146	0.00693	CcSEcCtD
Propylthiouracil—Agranulocytosis—Vinblastine—testicular cancer	0.00139	0.0066	CcSEcCtD
Propylthiouracil—Haemoglobin—Vinblastine—testicular cancer	0.00134	0.00638	CcSEcCtD
Propylthiouracil—Haemorrhage—Vinblastine—testicular cancer	0.00134	0.00635	CcSEcCtD
Propylthiouracil—Renal failure acute—Cisplatin—testicular cancer	0.0013	0.00619	CcSEcCtD
Propylthiouracil—Alopecia—Chlorambucil—testicular cancer	0.00129	0.00612	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Methotrexate—testicular cancer	0.00128	0.0061	CcSEcCtD
Propylthiouracil—Alopecia—Vinblastine—testicular cancer	0.00118	0.00561	CcSEcCtD
Propylthiouracil—Skin ulcer—Methotrexate—testicular cancer	0.00117	0.00554	CcSEcCtD
Propylthiouracil—Neuritis—Epirubicin—testicular cancer	0.00114	0.00541	CcSEcCtD
Propylthiouracil—Leukopenia—Chlorambucil—testicular cancer	0.00114	0.0054	CcSEcCtD
Propylthiouracil—Haemoglobin—Bleomycin—testicular cancer	0.00114	0.00539	CcSEcCtD
Propylthiouracil—Haemorrhage—Bleomycin—testicular cancer	0.00113	0.00536	CcSEcCtD
Propylthiouracil—Agranulocytosis—Dactinomycin—testicular cancer	0.0011	0.0052	CcSEcCtD
Propylthiouracil—Skin ulcer—Epirubicin—testicular cancer	0.00109	0.00519	CcSEcCtD
Propylthiouracil—Neuritis—Doxorubicin—testicular cancer	0.00105	0.00501	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00105	0.005	CcSEcCtD
Propylthiouracil—Hepatitis—Dactinomycin—testicular cancer	0.00105	0.005	CcSEcCtD
Propylthiouracil—Ageusia—Epirubicin—testicular cancer	0.00105	0.00499	CcSEcCtD
Propylthiouracil—Vertigo—Vinblastine—testicular cancer	0.00105	0.00497	CcSEcCtD
Propylthiouracil—Leukopenia—Vinblastine—testicular cancer	0.00104	0.00495	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Chlorambucil—testicular cancer	0.00102	0.00482	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—testicular cancer	0.00101	0.0048	CcSEcCtD
Propylthiouracil—Liver injury—Epirubicin—testicular cancer	0.00101	0.0048	CcSEcCtD
Propylthiouracil—Agranulocytosis—Ifosfamide—testicular cancer	0.001	0.00476	CcSEcCtD
Propylthiouracil—Alopecia—Bleomycin—testicular cancer	0.000998	0.00474	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—testicular cancer	0.000972	0.00461	CcSEcCtD
Propylthiouracil—Haemoglobin—Ifosfamide—testicular cancer	0.00097	0.00461	CcSEcCtD
Propylthiouracil—Haemorrhage—Ifosfamide—testicular cancer	0.000965	0.00458	CcSEcCtD
Propylthiouracil—Hepatitis—Ifosfamide—testicular cancer	0.000965	0.00458	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—testicular cancer	0.000936	0.00444	CcSEcCtD
Propylthiouracil—Vasculitis—Methotrexate—testicular cancer	0.000932	0.00442	CcSEcCtD
Propylthiouracil—Alopecia—Dactinomycin—testicular cancer	0.000931	0.00442	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Vinblastine—testicular cancer	0.00093	0.00442	CcSEcCtD
Propylthiouracil—Dyspepsia—Chlorambucil—testicular cancer	0.000913	0.00433	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Cisplatin—testicular cancer	0.000909	0.00431	CcSEcCtD
Propylthiouracil—Leukopenia—Bleomycin—testicular cancer	0.00088	0.00418	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Methotrexate—testicular cancer	0.000854	0.00405	CcSEcCtD
Propylthiouracil—Paraesthesia—Vinblastine—testicular cancer	0.000853	0.00405	CcSEcCtD
Propylthiouracil—Alopecia—Ifosfamide—testicular cancer	0.000853	0.00405	CcSEcCtD
Propylthiouracil—Myalgia—Bleomycin—testicular cancer	0.000837	0.00397	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Etoposide—testicular cancer	0.000833	0.00395	CcSEcCtD
Propylthiouracil—Jaundice—Etoposide—testicular cancer	0.000828	0.00393	CcSEcCtD
Propylthiouracil—Urticaria—Chlorambucil—testicular cancer	0.000824	0.00391	CcSEcCtD
Propylthiouracil—Leukopenia—Dactinomycin—testicular cancer	0.000821	0.0039	CcSEcCtD
Propylthiouracil—Body temperature increased—Chlorambucil—testicular cancer	0.00082	0.00389	CcSEcCtD
Propylthiouracil—Oedema—Bleomycin—testicular cancer	0.000803	0.00381	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Epirubicin—testicular cancer	0.000799	0.00379	CcSEcCtD
Propylthiouracil—Agranulocytosis—Etoposide—testicular cancer	0.000793	0.00376	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Bleomycin—testicular cancer	0.000786	0.00373	CcSEcCtD
Propylthiouracil—Myalgia—Dactinomycin—testicular cancer	0.000781	0.00371	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Methotrexate—testicular cancer	0.000774	0.00367	CcSEcCtD
Propylthiouracil—Vertigo—Ifosfamide—testicular cancer	0.000755	0.00358	CcSEcCtD
Propylthiouracil—Leukopenia—Ifosfamide—testicular cancer	0.000752	0.00357	CcSEcCtD
Propylthiouracil—Oedema—Dactinomycin—testicular cancer	0.000749	0.00355	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—testicular cancer	0.000739	0.00351	CcSEcCtD
Propylthiouracil—Alopecia—Cisplatin—testicular cancer	0.000735	0.00349	CcSEcCtD
Propylthiouracil—Hepatic failure—Methotrexate—testicular cancer	0.000735	0.00349	CcSEcCtD
Propylthiouracil—Pruritus—Chlorambucil—testicular cancer	0.000734	0.00348	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Dactinomycin—testicular cancer	0.000733	0.00348	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000731	0.00347	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Epirubicin—testicular cancer	0.000724	0.00344	CcSEcCtD
Propylthiouracil—Paraesthesia—Bleomycin—testicular cancer	0.000721	0.00342	CcSEcCtD
Propylthiouracil—Arthralgia—Ifosfamide—testicular cancer	0.000716	0.0034	CcSEcCtD
Propylthiouracil—Myalgia—Ifosfamide—testicular cancer	0.000716	0.0034	CcSEcCtD
Propylthiouracil—Renal failure acute—Methotrexate—testicular cancer	0.000715	0.00339	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Methotrexate—testicular cancer	0.0007	0.00332	CcSEcCtD
Propylthiouracil—Hepatic failure—Epirubicin—testicular cancer	0.000688	0.00326	CcSEcCtD
Propylthiouracil—Oedema—Ifosfamide—testicular cancer	0.000686	0.00326	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000682	0.00324	CcSEcCtD
Propylthiouracil—Alopecia—Etoposide—testicular cancer	0.000674	0.0032	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Ifosfamide—testicular cancer	0.000672	0.00319	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Doxorubicin—testicular cancer	0.00067	0.00318	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—testicular cancer	0.000669	0.00318	CcSEcCtD
Propylthiouracil—Vomiting—Chlorambucil—testicular cancer	0.000659	0.00313	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000655	0.00311	CcSEcCtD
Propylthiouracil—Dysgeusia—Etoposide—testicular cancer	0.00065	0.00309	CcSEcCtD
Propylthiouracil—Leukopenia—Cisplatin—testicular cancer	0.000649	0.00308	CcSEcCtD
Propylthiouracil—Urticaria—Bleomycin—testicular cancer	0.000638	0.00303	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—testicular cancer	0.000636	0.00302	CcSEcCtD
Propylthiouracil—Body temperature increased—Bleomycin—testicular cancer	0.000634	0.00301	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000625	0.00297	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—testicular cancer	0.000619	0.00294	CcSEcCtD
Propylthiouracil—Myalgia—Cisplatin—testicular cancer	0.000617	0.00293	CcSEcCtD
Propylthiouracil—Nausea—Chlorambucil—testicular cancer	0.000616	0.00292	CcSEcCtD
Propylthiouracil—Paraesthesia—Ifosfamide—testicular cancer	0.000616	0.00292	CcSEcCtD
Propylthiouracil—Somnolence—Ifosfamide—testicular cancer	0.00061	0.00289	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000606	0.00288	CcSEcCtD
Propylthiouracil—Vomiting—Vinblastine—testicular cancer	0.000604	0.00287	CcSEcCtD
Propylthiouracil—Vertigo—Etoposide—testicular cancer	0.000596	0.00283	CcSEcCtD
Propylthiouracil—Headache—Vinblastine—testicular cancer	0.000595	0.00283	CcSEcCtD
Propylthiouracil—Leukopenia—Etoposide—testicular cancer	0.000594	0.00282	CcSEcCtD
Propylthiouracil—Body temperature increased—Dactinomycin—testicular cancer	0.000592	0.00281	CcSEcCtD
Propylthiouracil—Oedema—Cisplatin—testicular cancer	0.000591	0.00281	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Cisplatin—testicular cancer	0.000579	0.00275	CcSEcCtD
Propylthiouracil—Pruritus—Bleomycin—testicular cancer	0.000568	0.0027	CcSEcCtD
Propylthiouracil—Nausea—Vinblastine—testicular cancer	0.000564	0.00268	CcSEcCtD
Propylthiouracil—Urticaria—Ifosfamide—testicular cancer	0.000545	0.00259	CcSEcCtD
Propylthiouracil—Body temperature increased—Ifosfamide—testicular cancer	0.000542	0.00257	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000539	0.00256	CcSEcCtD
Propylthiouracil—Paraesthesia—Cisplatin—testicular cancer	0.000531	0.00252	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Etoposide—testicular cancer	0.00053	0.00252	CcSEcCtD
Propylthiouracil—Vomiting—Bleomycin—testicular cancer	0.00051	0.00242	CcSEcCtD
Propylthiouracil—Drowsiness—Methotrexate—testicular cancer	0.000509	0.00241	CcSEcCtD
Propylthiouracil—Rash—Bleomycin—testicular cancer	0.000506	0.0024	CcSEcCtD
Propylthiouracil—Dermatitis—Bleomycin—testicular cancer	0.000506	0.0024	CcSEcCtD
Propylthiouracil—Paraesthesia—Etoposide—testicular cancer	0.000486	0.00231	CcSEcCtD
Propylthiouracil—Pruritus—Ifosfamide—testicular cancer	0.000485	0.0023	CcSEcCtD
Propylthiouracil—Somnolence—Etoposide—testicular cancer	0.000482	0.00229	CcSEcCtD
Propylthiouracil—Nausea—Bleomycin—testicular cancer	0.000477	0.00226	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—testicular cancer	0.000476	0.00226	CcSEcCtD
Propylthiouracil—Vomiting—Dactinomycin—testicular cancer	0.000476	0.00226	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—testicular cancer	0.000475	0.00225	CcSEcCtD
Propylthiouracil—Rash—Dactinomycin—testicular cancer	0.000472	0.00224	CcSEcCtD
Propylthiouracil—Body temperature increased—Cisplatin—testicular cancer	0.000467	0.00222	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—testicular cancer	0.000467	0.00222	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—testicular cancer	0.000464	0.0022	CcSEcCtD
Propylthiouracil—Haemoglobin—Methotrexate—testicular cancer	0.000459	0.00218	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—testicular cancer	0.000457	0.00217	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—testicular cancer	0.000457	0.00217	CcSEcCtD
Propylthiouracil—Nausea—Dactinomycin—testicular cancer	0.000445	0.00211	CcSEcCtD
Propylthiouracil—Agranulocytosis—Epirubicin—testicular cancer	0.000444	0.00211	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—testicular cancer	0.000441	0.00209	CcSEcCtD
Propylthiouracil—Vomiting—Ifosfamide—testicular cancer	0.000436	0.00207	CcSEcCtD
Propylthiouracil—Rash—Ifosfamide—testicular cancer	0.000432	0.00205	CcSEcCtD
Propylthiouracil—Dermatitis—Ifosfamide—testicular cancer	0.000432	0.00205	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000432	0.00205	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—testicular cancer	0.00043	0.00204	CcSEcCtD
Propylthiouracil—Haemoglobin—Epirubicin—testicular cancer	0.00043	0.00204	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—testicular cancer	0.000429	0.00204	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—testicular cancer	0.000428	0.00203	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—testicular cancer	0.000427	0.00203	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—testicular cancer	0.000427	0.00203	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—testicular cancer	0.000411	0.00195	CcSEcCtD
Propylthiouracil—Nausea—Ifosfamide—testicular cancer	0.000407	0.00193	CcSEcCtD
Propylthiouracil—Alopecia—Methotrexate—testicular cancer	0.000404	0.00192	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—testicular cancer	0.000397	0.00189	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—testicular cancer	0.000395	0.00188	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—testicular cancer	0.000395	0.00188	CcSEcCtD
Propylthiouracil—Dysgeusia—Methotrexate—testicular cancer	0.000389	0.00185	CcSEcCtD
Propylthiouracil—Pruritus—Etoposide—testicular cancer	0.000383	0.00182	CcSEcCtD
Propylthiouracil—Alopecia—Epirubicin—testicular cancer	0.000378	0.00179	CcSEcCtD
Propylthiouracil—Vomiting—Cisplatin—testicular cancer	0.000376	0.00178	CcSEcCtD
Propylthiouracil—Rash—Cisplatin—testicular cancer	0.000373	0.00177	CcSEcCtD
Propylthiouracil—Dermatitis—Cisplatin—testicular cancer	0.000372	0.00177	CcSEcCtD
Propylthiouracil—Dysgeusia—Epirubicin—testicular cancer	0.000364	0.00173	CcSEcCtD
Propylthiouracil—Vertigo—Methotrexate—testicular cancer	0.000357	0.0017	CcSEcCtD
Propylthiouracil—Leukopenia—Methotrexate—testicular cancer	0.000356	0.00169	CcSEcCtD
Propylthiouracil—Nausea—Cisplatin—testicular cancer	0.000351	0.00167	CcSEcCtD
Propylthiouracil—Alopecia—Doxorubicin—testicular cancer	0.000349	0.00166	CcSEcCtD
Propylthiouracil—Vomiting—Etoposide—testicular cancer	0.000344	0.00163	CcSEcCtD
Propylthiouracil—Rash—Etoposide—testicular cancer	0.000342	0.00162	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—testicular cancer	0.000341	0.00162	CcSEcCtD
Propylthiouracil—Headache—Etoposide—testicular cancer	0.000339	0.00161	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—testicular cancer	0.000338	0.00161	CcSEcCtD
Propylthiouracil—Myalgia—Methotrexate—testicular cancer	0.000338	0.00161	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—testicular cancer	0.000337	0.0016	CcSEcCtD
Propylthiouracil—Vertigo—Epirubicin—testicular cancer	0.000334	0.00159	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—testicular cancer	0.000333	0.00158	CcSEcCtD
Propylthiouracil—Nausea—Etoposide—testicular cancer	0.000322	0.00153	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—testicular cancer	0.000318	0.00151	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—testicular cancer	0.000317	0.0015	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—testicular cancer	0.000317	0.0015	CcSEcCtD
Propylthiouracil—Vertigo—Doxorubicin—testicular cancer	0.000309	0.00147	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—testicular cancer	0.000308	0.00146	CcSEcCtD
Propylthiouracil—Oedema—Epirubicin—testicular cancer	0.000304	0.00144	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Epirubicin—testicular cancer	0.000297	0.00141	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000296	0.0014	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—testicular cancer	0.000293	0.00139	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—testicular cancer	0.000293	0.00139	CcSEcCtD
Propylthiouracil—Paraesthesia—Methotrexate—testicular cancer	0.000291	0.00138	CcSEcCtD
Propylthiouracil—Somnolence—Methotrexate—testicular cancer	0.000288	0.00137	CcSEcCtD
Propylthiouracil—Dyspepsia—Methotrexate—testicular cancer	0.000286	0.00136	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—testicular cancer	0.000281	0.00133	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000277	0.00131	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—testicular cancer	0.000275	0.00131	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—testicular cancer	0.000273	0.00129	CcSEcCtD
Propylthiouracil—Somnolence—Epirubicin—testicular cancer	0.00027	0.00128	CcSEcCtD
Propylthiouracil—Dyspepsia—Epirubicin—testicular cancer	0.000267	0.00127	CcSEcCtD
Propylthiouracil—Urticaria—Methotrexate—testicular cancer	0.000258	0.00122	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—testicular cancer	0.000257	0.00122	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000256	0.00122	CcSEcCtD
Propylthiouracil—Paraesthesia—Doxorubicin—testicular cancer	0.000252	0.0012	CcSEcCtD
Propylthiouracil—Somnolence—Doxorubicin—testicular cancer	0.00025	0.00119	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—testicular cancer	0.000247	0.00117	CcSEcCtD
Propylthiouracil—Urticaria—Epirubicin—testicular cancer	0.000241	0.00114	CcSEcCtD
Propylthiouracil—Body temperature increased—Epirubicin—testicular cancer	0.00024	0.00114	CcSEcCtD
Propylthiouracil—Pruritus—Methotrexate—testicular cancer	0.00023	0.00109	CcSEcCtD
Propylthiouracil—Urticaria—Doxorubicin—testicular cancer	0.000223	0.00106	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—testicular cancer	0.000222	0.00105	CcSEcCtD
Propylthiouracil—Pruritus—Epirubicin—testicular cancer	0.000215	0.00102	CcSEcCtD
Propylthiouracil—Vomiting—Methotrexate—testicular cancer	0.000206	0.000979	CcSEcCtD
Propylthiouracil—Rash—Methotrexate—testicular cancer	0.000205	0.000971	CcSEcCtD
Propylthiouracil—Dermatitis—Methotrexate—testicular cancer	0.000204	0.00097	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—testicular cancer	0.000203	0.000965	CcSEcCtD
Propylthiouracil—Pruritus—Doxorubicin—testicular cancer	0.000199	0.000944	CcSEcCtD
Propylthiouracil—Vomiting—Epirubicin—testicular cancer	0.000193	0.000916	CcSEcCtD
Propylthiouracil—Nausea—Methotrexate—testicular cancer	0.000193	0.000915	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—testicular cancer	0.000191	0.000909	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—testicular cancer	0.000191	0.000908	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—testicular cancer	0.00019	0.000903	CcSEcCtD
Propylthiouracil—Nausea—Epirubicin—testicular cancer	0.00018	0.000856	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—testicular cancer	0.000179	0.000848	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—testicular cancer	0.000177	0.000841	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—testicular cancer	0.000177	0.00084	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—testicular cancer	0.000176	0.000835	CcSEcCtD
Propylthiouracil—Nausea—Doxorubicin—testicular cancer	0.000167	0.000792	CcSEcCtD
